Essa Pharma Inc.

(EPI:CA)

By |

Profile

ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Contact Information

Website: www.essapharmaceuticals.com
Main Phone: +1 778 331-0962
Address: 999 West Broadway Street
Address 2: Suite 720
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V5Z 1K5

Issuer Information

Exchange: CDX
CEO: David R. Parkinson
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.60 $ 0.50 (16.13%)
Last Price 3.60 Change $ 0.50 Change % 16.13 Tick N/A
Bid 3.15 Bid Size 100.00 Ask 3.70 Ask Size 100.00
Open 3.40 High 3.60 Low 3.40 Prev Close 3.10
Last Trade Volume 1,074 52 Wk Hi 7.15 52 Wk Low 3.00
Market Cap 22.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 6,311,098.00 EPS (TTM) -3.99 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 12.6 12.6 12.6 12.6
Mean Target Price Estimate 15.3 15.3 15.3 15.3
Standard Deviation 3.82 3.82 3.82 3.82
Date of Most Recent Estimate 03/26/18 03/26/18 03/26/18 03/26/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1